Chromatin and chromatin-modifying proteins in adipogenesis

被引:40
|
作者
Musri, Melina M.
Gomis, Ramon
Parrizas, Marcelina [1 ]
机构
[1] Univ Barcelona, Endocrinol & Nutr Unit, IDIBAPS, Hosp Clin, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, Dept Biochem & Mol Genet, E-08036 Barcelona, Spain
关键词
chromatin; histones; coregulators; transcription; adipogenesis;
D O I
10.1139/O07-068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long considered scarcely more than an uninteresting energy depot, adipose tissue has recently achieved star status. Far from being mere fat droplets, the adipocytes secrete a number of hormones and bioactive peptides, collectively known as adipokines, which participate in the regulation of a variety of functions, from haemostasis to angiogenesis to energy balance. Adipose tissue constitutes a bona-fide endocrine organ whose main dysfunctions, obesity and lipodystrophy, are related to the development of diabetes, hypertension, or dyslipidemia. The renewed interest in this tissue has prompted an escalation in the number of studies focusing on every aspect of the biology of the adipose cell, in the belief that a detailed knowledge of the mechanisms involved in the differentiation and function of adipocytes may contribute new therapeutical approaches to the treatment of such alarming medical problems. Adipogenesis is the result of an intertwined network of transcription factors and coregulators with chromatin-modifying activities that together, are responsible for the establishment of the gene expression pattern of mature adipocytes. Although the exquisitely regulated transcription factor cascade controlling adipogenesis has been extensively studied, the role of chromatin and chromatin-modifying proteins has become apparent only in recent times.
引用
收藏
页码:397 / 410
页数:14
相关论文
共 50 条
  • [1] Chromatin-modifying proteins in cancer
    Fog, Cathrine K.
    Jensen, Klaus T.
    Lund, Anders H.
    APMIS, 2007, 115 (10) : 1060 - 1089
  • [2] Chromatin-modifying and -remodeling complexes
    Kornberg, RD
    Lorch, Y
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (02) : 148 - 151
  • [3] The Nature of Actin-Family Proteins in Chromatin-Modifying Complexes
    Klages-Mundt, Naeh L.
    Kumar, Ashok
    Zhang, Yuexuan
    Kapoor, Prabodh
    Shen, Xuetong
    FRONTIERS IN GENETICS, 2018, 9
  • [4] Chromatin-modifying enzymes as modulators of reprogramming
    Onder, Tamer T.
    Kara, Nergis
    Cherry, Anne
    Sinha, Amit U.
    Zhu, Nan
    Bernt, Kathrin M.
    Cahan, Patrick
    Mancarci, B. Ogan
    Unternaehrer, Juli
    Gupta, Piyush B.
    Lander, Eric S.
    Armstrong, Scott A.
    Daley, George Q.
    NATURE, 2012, 483 (7391) : 598 - U119
  • [5] Allosteric Regulation of Chromatin-Modifying Enzymes
    Kim, Jung-Ae
    Kwon, Minjung
    Kim, Jaehoon
    BIOCHEMISTRY, 2019, 58 (01) : 15 - 23
  • [6] Chromatin-modifying enzymes in transcription and cancer
    Kouzarides, T
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 741 - 743
  • [7] Chromatin-modifying enzymes as modulators of reprogramming
    Tamer T. Onder
    Nergis Kara
    Anne Cherry
    Amit U. Sinha
    Nan Zhu
    Kathrin M. Bernt
    Patrick Cahan
    B. Ogan Mancarci
    Juli Unternaehrer
    Piyush B. Gupta
    Eric S. Lander
    Scott A. Armstrong
    George Q. Daley
    Nature, 2012, 483 : 598 - 602
  • [8] New nomenclature for chromatin-modifying enzymes
    Allis, C. David
    Berger, Shelley L.
    Cote, Jacques
    Dent, Sharon
    Jenuwien, Thomas
    Kouzarides, Tony
    Pillus, Lorraine
    Reinberg, Danny
    Shi, Yang
    Shiekhattar, Ramin
    Shilatifard, Ali
    Workman, Jerry
    Zhang, Yi
    CELL, 2007, 131 (04) : 633 - 636
  • [9] The therapeutic uses of chromatin-modifying agents
    Mai, Antonello
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (06) : 835 - 851
  • [10] Promoter targeting of chromatin-modifying complexes
    Hassan, AH
    Neely, KE
    Vignali, M
    Reese, JC
    Workman, JL
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 : D1054 - D1064